The Topical Drug Delivery Market Size was valued at USD 225.73 billion in 2022 and is expected to reach USD 449.79 billion by 2030 and grow at a CAGR of 9% over the forecast period 2023-2030.
The topical drug delivery market has witnessed significant growth in recent years, driven by the increasing prevalence of skin diseases and disorders, such as acne, psoriasis, and eczema. Topical drug delivery refers to the administration of medications directly onto the skin surface for localized treatment.
One of the key advantages of topical drug delivery is its ability to target specific areas, providing a more concentrated and effective treatment compared to systemic medications. This targeted approach minimizes potential side effects and reduces the risk of drug interactions.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2580
Furthermore, advancements in technology have led to the development of innovative topical drug delivery systems, including creams, gels, ointments, patches, and sprays. These formulations offer improved bioavailability and enhanced patient compliance due to their ease of application.
The rising geriatric population worldwide is also contributing to the growth of the topical drug delivery market. Elderly individuals often face challenges with swallowing pills or capsules, making topical treatments a preferred option for them. Additionally, with age comes an increased susceptibility to various skin conditions such as dryness, eczema, and psoriasis. Topical drug delivery systems provide targeted relief for these ailments, offering a convenient and effective solution for the elderly population. Moreover, the ease of application of topical formulations allows for self-administration, reducing the need for caregiver assistance and promoting independence among the elderly. As the geriatric population continues to grow, the demand for topical drug delivery systems is expected to rise, further driving the expansion of the market.
KEY MARKET SEGMENTS
- Semi-Solid Formulations
- Liquid Formulations
- Solid Formulations
- Transdermal Products
by Route of Administration
- Dermal Drug Delivery
- Ophthalmic Drug Delivery
- Rectal Drug Delivery
- Vaginal Drug Delivery
- Nasal Drug Delivery
by Facility of Use
- Home Care Settings
- Hospitals & Clinics
- Burn Centers
- Other Facilities
Major Players Listed in the Report are as Follows:
Valeant Pharmaceuticals International, Inc., Crescita Therapeutics Inc., MedPharm Group Ltd., 3M Company, Bayer AG, Novartis AG, Janssen Global Services, LLC, and Cipla, Galderma S.A., GlaxoSmithKline plc. and other players
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)